Evidence map›Paper›PMID 35744875›Full record

ArticleMolecules (Basel, Switzerland)2022

Synthesis and Characterization of Novel Heterocyclic Chalcones from 1-Phenyl-1

Arminas Urbonavičius, Graziana Fortunato, Emilija Ambrazaitytė, Elena Plytninkienė, Aurimas Bieliauskas, Vaida Milišiūnaitė, Renzo Luisi, Eglė Arbačiauskienė, Sonata Krikštolaitytė, Algirdas Šačkus

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Synthesis and Characterization of New Pyrano[2,3-Molecules (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arminas UrbonavičiusDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų Pl. 19, 50254 Kaunas, Lithuania.
Graziana FortunatoDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų Pl. 19, 50254 Kaunas, Lithuania.
Emilija AmbrazaitytėDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų Pl. 19, 50254 Kaunas, Lithuania.
Elena PlytninkienėDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų Pl. 19, 50254 Kaunas, Lithuania.
Aurimas BieliauskasInstitute of Synthetic Chemistry, Kaunas University of Technology, K. Baršausko g. 59, 51423 Kaunas, Lithuania.ORCID 0000-0002-3838-261X
Vaida MilišiūnaitėDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų Pl. 19, 50254 Kaunas, Lithuania.
Renzo LuisiDepartment of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.ORCID 0000-0002-9882-7908
Eglė ArbačiauskienėDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų Pl. 19, 50254 Kaunas, Lithuania.ORCID 0000-0003-1365-9990
Sonata KrikštolaitytėDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų Pl. 19, 50254 Kaunas, Lithuania.
Algirdas ŠačkusDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų Pl. 19, 50254 Kaunas, Lithuania.

Funding

Doctoral Fund of Kaunas University of Technology A-410, approved 26th of June, 2019Research Council of Lithuania S-MIP-20-60
6 · The paper itself

Abstract

An efficient synthetic route to construct diverse pyrazole-based chalcones from 1-phenyl-1

Indexed as

ChalconeChalconesMagnetic Resonance SpectroscopyOxazolesPyrazolesChalconeChalconesOxazolesPyrazoles1,2-oxazole (isoxazole)15N-labeled 1,2-oxazoleClaisen–Schmidt condensationheterocyclic chalconespyrazolepyridine

Identifiers

PMID35744875
PMCPMC9227189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.